EXAGEN INC. Tax Withholding Paid on Stock Awards
EXAGEN INC. (XGN) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2024-03-18
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $239.00K.
- EXAGEN INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $0.00 derived: sum of 2 quarters · filed 2024-03-18 | $0.00 derived: sum of 3 quarters · filed 2024-03-18 | $0.00 10-K · filed 2024-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $15.00K derived: sum of 4 quarters · filed 2024-03-18 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $15.00K derived: sum of 3 quarters · filed 2024-03-18 | $17.00K derived: sum of 4 quarters · filed 2024-03-18 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $15.00K derived: sum of 2 quarters · filed 2024-03-18 | $17.00K derived: sum of 3 quarters · filed 2024-03-18 | $124.00K derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $17.00K derived: sum of 2 quarters · filed 2024-03-18 | $124.00K derived: sum of 3 quarters · filed 2024-03-18 | $239.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $109.00K derived: sum of 2 quarters · filed 2023-11-13 | $224.00K 10-Q · filed 2023-11-13 | $224.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $222.00K 10-Q · filed 2023-08-07 | $222.00K derived: sum of 3 quarters · filed 2023-08-07 | $222.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $115.00K 10-Q · filed 2023-05-15 | $115.00K derived: sum of 2 quarters · filed 2023-05-15 | $115.00K derived: sum of 3 quarters · filed 2023-05-15 | $115.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $0.00 derived: sum of 3 quarters · filed 2023-03-20 | $0.00 10-K · filed 2023-03-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $0.00 derived: sum of 2 quarters · filed 2022-11-21 | $0.00 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21 | $0.00 10-Q/A · filed 2022-11-21 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |